1182363

Hikma Pharmaceuticals USA INC — FEI 1510690

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Columbus, OH (United States)